“ What you really want to be able to do is have that impact on society , to impact patients , impact the world in some way ”
Kevin Costa , CSO at Novoheart
43 ing to fix a currently broken and expensive system for accurately pre-screening the effectiveness and safety of new drug formulas .
While Costa is deeply passionate about the science involved , he credits co-founder Professor Ronald Li with helping him to realise how this could be applied from a business standpoint to help save lives . Costa is a biomedical engineer and Li brought key expertise in electrophysiology – a “ perfect marriage ” of skills , according to the CSO .
“ The heart ’ s kind of a cool organ as it ’ s really complicated in a way ,” explains Costa . “ You ’ ve got the mechanics of how the heart wall moves , there ’ s fluid mechanics of blood flowing through it , there ’ s the electrophysiology , so the electrical signals running through the tissue …
“ Most institutions will specialise in one of these areas , but there are not a lot of investigators with the breadth of expertise to understand all of that , so it was a nice coincidence that Ron came in with the expertise in electrophysiology .
www . healthcareglobal . com